hotspot -WSS

hotspot

author：knowledge 2025-08-12 08:27:26 - browse：62859

Scanned cerebellum of a mouse brain, affected by Niemann-Pick Type C, shown in pink and teal — biotech coverage from STAT — The cerebellum of a mouse brain affected by Niemann-Pick Type C. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health

About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo drug, probing its effects on people with balance disorders, when she thought of another, very sick group of patients.

A graduate student and medical resident at the German Center for Vertigo and Balance Disorders, in Munich, Bremova-Ertl often saw patients with Niemann-Pick Type C, a rare, genetic disease that slowly kills neurons.

NPC has a range of manifestations. When symptoms appear in early childhood, it is often fatal before adulthood. When it manifests later, it can be milder. But it’s always degenerative and leads to a cluster of challenges: cognitive decline, difficulty with speech and swallowing, enlarged liver, low muscle tone, and, notably, difficulty with balance and muscle control. Researchers and a fervent group of parents were working to develop medicines, but little had yet worked.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Chronically ill young patients struggle to find fertility info

WSS

Following judge's order, DOJ releases slightly less

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Feng Zhang, Grail founder join forces on new gene editing startup

Feng Zhang, Grail founder join forces on new gene editing startup

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

hotspot

hotspot

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

Walensky prepares to leave CDC — and Congress — behind

Federal weight loss drug coverage is 30 years out of date

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The biotech scorecard for Q1: 17 stock

Bright Health sells Medicare Advantage business to Molina

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

How to save PrEP access — and even expand it

5 shark bites reported on Long Island as officials deploy surveillance drones

hotspot

JPM: CVS says Medicare Advantage patients are impacting profits

Chronically ill young patients struggle to find fertility info

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Condition critical? Britain's beloved but battered National Health Service turns 75

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

focus

focus

Wikipedia

hotspot